
The global Biological Product Manufacturing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Report includes an overview of the development of the Biological Product Manufacturing industry chain, the market status of Hospitals (Monoclonal Antibodies, Recombinant Proteins), Specialized Clinics (Monoclonal Antibodies, Recombinant Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biological Product Manufacturing.
Regionally, the report analyzes the Biological Product Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biological Product Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biological Product Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biological Product Manufacturing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Recombinant Proteins).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biological Product Manufacturing market.
Regional Analysis: The report involves examining the Biological Product Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biological Product Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biological Product Manufacturing:
Company Analysis: Report covers individual Biological Product Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biological Product Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialized Clinics).
Technology Analysis: Report covers specific technologies relevant to Biological Product Manufacturing. It assesses the current state, advancements, and potential future developments in Biological Product Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biological Product Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biological Product Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Market segment by Application
Hospitals
Specialized Clinics
Government Research Institutes
Market segment by players, this report covers
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biological Product Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biological Product Manufacturing, with revenue, gross margin and global market share of Biological Product Manufacturing from 2019 to 2024.
Chapter 3, the Biological Product Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biological Product Manufacturing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Product Manufacturing.
Chapter 13, to describe Biological Product Manufacturing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Biological Product Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biological Product Manufacturing by Type
1.3.1 Overview: Global Biological Product Manufacturing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biological Product Manufacturing Consumption Value Market Share by Type in 2023
1.3.3 Monoclonal Antibodies
1.3.4 Recombinant Proteins
1.3.5 Growth Hormones
1.3.6 Beta Interferon
1.3.7 Therapeutic Enzymes
1.4 Global Biological Product Manufacturing Market by Application
1.4.1 Overview: Global Biological Product Manufacturing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialized Clinics
1.4.4 Government Research Institutes
1.5 Global Biological Product Manufacturing Market Size & Forecast
1.6 Global Biological Product Manufacturing Market Size and Forecast by Region
1.6.1 Global Biological Product Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biological Product Manufacturing Market Size by Region, (2019-2030)
1.6.3 North America Biological Product Manufacturing Market Size and Prospect (2019-2030)
1.6.4 Europe Biological Product Manufacturing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biological Product Manufacturing Market Size and Prospect (2019-2030)
1.6.6 South America Biological Product Manufacturing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biological Product Manufacturing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biological Product Manufacturing Product and Solutions
2.1.4 Novartis Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 F.Hoffmann-La Roche
2.2.1 F.Hoffmann-La Roche Details
2.2.2 F.Hoffmann-La Roche Major Business
2.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Product and Solutions
2.2.4 F.Hoffmann-La Roche Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 F.Hoffmann-La Roche Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Biological Product Manufacturing Product and Solutions
2.3.4 Merck Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Biological Product Manufacturing Product and Solutions
2.4.4 Bayer Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Biological Product Manufacturing Product and Solutions
2.5.4 Lonza Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lonza Recent Developments and Future Plans
2.6 China Biologic Products
2.6.1 China Biologic Products Details
2.6.2 China Biologic Products Major Business
2.6.3 China Biologic Products Biological Product Manufacturing Product and Solutions
2.6.4 China Biologic Products Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 China Biologic Products Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Biological Product Manufacturing Product and Solutions
2.7.4 Pfizer Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biological Product Manufacturing Product and Solutions
2.8.4 Sanofi Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Teva Pharmaceutical Industries
2.9.1 Teva Pharmaceutical Industries Details
2.9.2 Teva Pharmaceutical Industries Major Business
2.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Product and Solutions
2.9.4 Teva Pharmaceutical Industries Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Biological Product Manufacturing Product and Solutions
2.10.4 Amgen Biological Product Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Amgen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biological Product Manufacturing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biological Product Manufacturing by Company Revenue
3.2.2 Top 3 Biological Product Manufacturing Players Market Share in 2023
3.2.3 Top 6 Biological Product Manufacturing Players Market Share in 2023
3.3 Biological Product Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Biological Product Manufacturing Market: Region Footprint
3.3.2 Biological Product Manufacturing Market: Company Product Type Footprint
3.3.3 Biological Product Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biological Product Manufacturing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biological Product Manufacturing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Biological Product Manufacturing Consumption Value Market Share by Application (2019-2024)
5.2 Global Biological Product Manufacturing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Biological Product Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Biological Product Manufacturing Consumption Value by Application (2019-2030)
6.3 North America Biological Product Manufacturing Market Size by Country
6.3.1 North America Biological Product Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Biological Product Manufacturing Market Size and Forecast (2019-2030)
6.3.3 Canada Biological Product Manufacturing Market Size and Forecast (2019-2030)
6.3.4 Mexico Biological Product Manufacturing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Biological Product Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Biological Product Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Biological Product Manufacturing Market Size by Country
7.3.1 Europe Biological Product Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Biological Product Manufacturing Market Size and Forecast (2019-2030)
7.3.3 France Biological Product Manufacturing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biological Product Manufacturing Market Size and Forecast (2019-2030)
7.3.5 Russia Biological Product Manufacturing Market Size and Forecast (2019-2030)
7.3.6 Italy Biological Product Manufacturing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Biological Product Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biological Product Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biological Product Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biological Product Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Biological Product Manufacturing Market Size and Forecast (2019-2030)
8.3.3 Japan Biological Product Manufacturing Market Size and Forecast (2019-2030)
8.3.4 South Korea Biological Product Manufacturing Market Size and Forecast (2019-2030)
8.3.5 India Biological Product Manufacturing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biological Product Manufacturing Market Size and Forecast (2019-2030)
8.3.7 Australia Biological Product Manufacturing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Biological Product Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Biological Product Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Biological Product Manufacturing Market Size by Country
9.3.1 South America Biological Product Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Biological Product Manufacturing Market Size and Forecast (2019-2030)
9.3.3 Argentina Biological Product Manufacturing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Biological Product Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biological Product Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biological Product Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biological Product Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Biological Product Manufacturing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biological Product Manufacturing Market Size and Forecast (2019-2030)
10.3.4 UAE Biological Product Manufacturing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Biological Product Manufacturing Market Drivers
11.2 Biological Product Manufacturing Market Restraints
11.3 Biological Product Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biological Product Manufacturing Industry Chain
12.2 Biological Product Manufacturing Upstream Analysis
12.3 Biological Product Manufacturing Midstream Analysis
12.4 Biological Product Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Ìý
Ìý
*If Applicable.
